Mezlocillin for treatment of infections in cancer patients.
Mezlocillin, at a dose of 3 g intravenously over a 2-h period every 4 h, was used for the treatment of 92 episodes of documented infections in 75 myelosuppressed cancer patients. The response rate in 59 evaluable bacterial infections was 46%. Eight of 23 patients with septicemia (35%) responded. The...
Na minha lista:
| Udgivet i: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology (ASM)
1980
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC283920/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6447474/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.17.6.1008 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|